Serum Elafin as a Potential Marker of Disease Activity in Behçet's Disease
Background: Elafin is a serine protease inhibitor with anti-inflammatory properties. It is expressed in various epithelial tissues with increased production under inflammatory conditions. Increased tissue elafin expression in Behçet's disease (BD) lesions has previously been demonstrated. Aims...
Saved in:
Main Authors: | Armagan Kutlay (Author), Afet Akdag Kose (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of serum elafin as a possible inflammatory marker in psoriasis
by: Samar Mohamed Elsaid Alghonemy, et al.
Published: (2020) -
Serum Melatonin Levels in Patients with Behçet's Disease
by: Ayhan Kul, et al.
Published: (2020) -
Behcet's Disease
Published: (2017) -
Serum Calprotectin and Iron Metabolism Biomarker Levels in Behçet's Disease
by: Ahmet Karadağ, et al.
Published: (2021) -
BEHCET'S DISEASE IN CHILDREN
by: Z.S. Alekberova
Published: (2009)